Skip Navigation

Photo-dynamic therapy for early oesophageal cancer

Guidance issued Guidance issued
 
IP Guidance Number: IPG200
 
Summary:
 The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on photo-dynamic therapy for early oesophageal cancer.
Description:
 Oesophageal cancer usually originates in the lining of the oesophagus and can develop in the upper, middle, or lower section of the organ. Photodynamic therapy uses light to kill cancer cells. The patients takes a drug that makes cancerous cells sensitive to light. Then the doctor shines a very bright light onto the oesophagous which activates the drug and kills the cells.
Arrangements:

Other (see guidance)
Topic Area:

Cancer
Digestive system
Therapeutic procedures
Specialty:

Clinical oncology
Gastro-enterology
Medical oncology
Specialist advice has
been sought from:

Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland

British Society of Gastroenterology

British Association of Surgical Oncology
Date notified to NICE: 08 April 2005
Provisional Consultation Date: Autumn 2006
Guidance Publication Date: 13 December 2006
Contact Details:
Project Manager
(for general enquiries or comments)		 Ben Doak
ip@nice.org.uk
Technical Lead
(for procedure specific enquiries or comments) 		Steven Barnes
ip@nice.org.uk
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA
Links:

Search NICE guidance


Advanced guidance search

Related information

See NICE guidance in practice

Related guidance

Click the links below to see guidance on similar topics

Order NICE guidance

Order printed copies of our guidance